Correlation Between Hemogenyx Pharmaceuticals and Gain Therapeutics
Can any of the company-specific risk be diversified away by investing in both Hemogenyx Pharmaceuticals and Gain Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hemogenyx Pharmaceuticals and Gain Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hemogenyx Pharmaceuticals Plc and Gain Therapeutics, you can compare the effects of market volatilities on Hemogenyx Pharmaceuticals and Gain Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hemogenyx Pharmaceuticals with a short position of Gain Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hemogenyx Pharmaceuticals and Gain Therapeutics.
Diversification Opportunities for Hemogenyx Pharmaceuticals and Gain Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Hemogenyx and Gain is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Hemogenyx Pharmaceuticals Plc and Gain Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gain Therapeutics and Hemogenyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hemogenyx Pharmaceuticals Plc are associated (or correlated) with Gain Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gain Therapeutics has no effect on the direction of Hemogenyx Pharmaceuticals i.e., Hemogenyx Pharmaceuticals and Gain Therapeutics go up and down completely randomly.
Pair Corralation between Hemogenyx Pharmaceuticals and Gain Therapeutics
If you would invest 0.31 in Hemogenyx Pharmaceuticals Plc on September 1, 2024 and sell it today you would earn a total of 0.00 from holding Hemogenyx Pharmaceuticals Plc or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Hemogenyx Pharmaceuticals Plc vs. Gain Therapeutics
Performance |
| Timeline |
| Hemogenyx Pharmaceuticals |
| Gain Therapeutics |
Hemogenyx Pharmaceuticals and Gain Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hemogenyx Pharmaceuticals and Gain Therapeutics
The main advantage of trading using opposite Hemogenyx Pharmaceuticals and Gain Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hemogenyx Pharmaceuticals position performs unexpectedly, Gain Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gain Therapeutics will offset losses from the drop in Gain Therapeutics' long position.| Hemogenyx Pharmaceuticals vs. Rigel Pharmaceuticals | Hemogenyx Pharmaceuticals vs. Geron | Hemogenyx Pharmaceuticals vs. Verastem | Hemogenyx Pharmaceuticals vs. Immutep Ltd ADR |
| Gain Therapeutics vs. Tff Pharmaceuticals | Gain Therapeutics vs. Eliem Therapeutics | Gain Therapeutics vs. Inhibrx | Gain Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |